Drug Type Small molecule drug |
Synonyms BMS P5, BMS-P5, BMSP5 |
Target |
Mechanism PAD4 inhibitors(peptidyl arginine deiminase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H33ClN6O2 |
InChIKeyUMXWDEKCDIDCBA-VASSOYJASA-N |
CAS Registry1549811-36-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | US | - |